Pharma

Lupin Ltd

LUPIN · NSE · INE326A01037
₹2,072-0.96%consolidatedstandalone
Thursday, 10 Sept 202611:16 am
Sentiment13 · Extreme Fear
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE27.0%
ROCE27.0%
ROE27.0%
1Y Return-4.91%
Avg. Volume1.0M

Price Chart

2,5152,3632,2102,0581,90618.8L37.6LSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹1,900₹2,072₹2,529.5
52W Low52W High

About

Lupin Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price₹2,072
52W High / Low₹2,529.5 / ₹1,900
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE27.0%
1Y Return-4.91%
Day Change-0.96%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹29,967 Cr₹27,958 Cr₹22,708 Cr
Expenses₹20,428 Cr₹19,798 Cr₹17,430 Cr
Operating Profit₹9,538 Cr₹8,160 Cr₹5,278 Cr
OPM %32.0%29.0%23.0%
Other Income₹-82 Cr₹523 Cr₹202 Cr
Depreciation₹1,529 Cr₹1,376 Cr₹1,169 Cr
Interest₹452 Cr₹434 Cr₹295 Cr
Profit Before Tax₹7,474 Cr₹6,873 Cr₹4,015 Cr
Tax₹1,923 Cr₹1,518 Cr₹709 Cr
Net Profit₹5,551 Cr₹5,355 Cr₹3,306 Cr
EPS (₹)121.0116.771.9
Dividend Payout %—15%17%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹8,277 Cr₹7,475 Cr₹7,168 Cr₹7,048 Cr
Expenses₹5,827 Cr₹4,989 Cr₹4,906 Cr₹4,706 Cr
Operating Profit₹2,450 Cr₹2,486 Cr₹2,262 Cr₹2,341 Cr
OPM %30.0%33.0%32.0%33.0%
Depreciation₹453 Cr₹447 Cr₹313 Cr₹317 Cr
Interest₹110 Cr₹120 Cr₹115 Cr₹108 Cr
Net Profit₹1,417 Cr₹1,469 Cr₹1,181 Cr₹1,485 Cr
EPS (₹)31.031.925.732.4
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹91 Cr₹91 Cr₹91 Cr
Reserves₹22,357 Cr₹17,112 Cr₹14,199 Cr
Borrowings₹6,616 Cr₹5,448 Cr₹2,922 Cr
Other Liabilities₹9,082 Cr₹6,327 Cr₹6,539 Cr
Total Liabilities₹38,146 Cr₹28,978 Cr₹23,751 Cr
Assets
Fixed Assets₹10,994 Cr₹9,719 Cr₹8,878 Cr
Investments₹3,670 Cr₹1,146 Cr₹1,075 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹22,466 Cr₹17,596 Cr₹13,026 Cr
Total Assets₹38,146 Cr₹28,978 Cr₹23,751 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹7,334 Cr₹-3,865 Cr₹-846 Cr₹2,624 Cr
FY25₹3,000 Cr₹-4,172 Cr₹1,732 Cr₹560 Cr
FY24₹3,648 Cr₹-1,712 Cr₹-2,184 Cr₹-248 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-08Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE Filing2026-08-07Lupin Ltd (BOM:500257) (Q1 2027) Earnings Call Highlights: Record Revenue and Strategic ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.